Abstract
Updated Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have